Advertisement
Singapore markets closed
  • Straits Times Index

    3,497.78
    +22.72 (+0.65%)
     
  • Nikkei

    41,190.68
    -1,033.34 (-2.45%)
     
  • Hang Seng

    18,293.38
    +461.05 (+2.59%)
     
  • FTSE 100

    8,252.91
    +29.57 (+0.36%)
     
  • Bitcoin USD

    58,700.45
    +1,006.54 (+1.74%)
     
  • CMC Crypto 200

    1,227.78
    +29.21 (+2.44%)
     
  • S&P 500

    5,615.35
    +30.81 (+0.55%)
     
  • Dow

    40,000.90
    +247.15 (+0.62%)
     
  • Nasdaq

    18,398.45
    +115.04 (+0.63%)
     
  • Gold

    2,416.00
    -5.90 (-0.24%)
     
  • Crude Oil

    82.18
    -0.44 (-0.53%)
     
  • 10-Yr Bond

    4.1890
    -0.0040 (-0.10%)
     
  • FTSE Bursa Malaysia

    1,619.06
    -4.06 (-0.25%)
     
  • Jakarta Composite Index

    7,327.58
    +27.17 (+0.37%)
     
  • PSE Index

    6,648.23
    +38.99 (+0.59%)
     

Goldman Sachs updates US Conviction List for June

Goldman Sachs on Monday updated its popular ‘US Conviction List - Director’s Cut,’ adding five stocks to its curated selection of Buy-rated stocks from its US coverage.

The five names added in the June update include Edwards Lifesciences Corp (NYSE:EW), Enphase Energy (NASDAQ:ENPH), Sempra Energy (NYSE:SRE), Teradyne (NASDAQ:TER), and Brixmor Property (NYSE:BRX) Group.

For Edwards Lifesciences, the firm's bullishness is based on the company's successful transition in its product cycle and the potential to expand the market for its Transcatheter Aortic Valve Replacement (TAVR) product line. The growth is expected to come from treating a broader patient demographic, including younger, asymptomatic patients.

“Look for new products and an expanded TAM to drive accelerating top-line growth in 2025 and put sales and EPS estimates 2-8% above Factset consensus in 2025-2027E,” analysts wrote in the note.

ADVERTISEMENT

Enphase Energy's inclusion comes as Goldman foresees a revenue rebound, especially from the critical California market. The firm notes that a previous inventory de-stocking cycle, influenced by regulation, is coming to an end.

“Additionally, the company’s still nascent home battery segment is poised to benefit from changing residential electricity economics that make it more profitable to store electricity at home than sell it back to the grid at certain times of day,” Goldman’s note states.

Meanwhile, the firm’s analysts are also optimistic about Sempra Energy's growth prospects as its Texas utility, Oncor, is expected to benefit from the state's business, infrastructure, and population expansion.

Analysts also highlight the company’s capital expenditure growth outlook and a solid Liquified Natural Gas (LNG) pipeline, which are anticipated to support expansion in its regulated utilities.

Lastly, automatic test equipment (ATE) designer Teradyne made its way to Goldman’s Conviction List as analysts expect to see a sales inflection point, mainly due to depleted inventory levels and a forthcoming positive earnings cycle.

The firm also cites potential earnings tailwinds from a recovery in sales to a major client, new product initiatives, “and a cyclical recovery in its Robots business (10% of sales) should also provide tailwinds for earnings,” analysts noted.

While these five stocks have been added, First Solar (NASDAQ:FSLR), Southern Company (NYSE:SO), Target Corporation (NYSE:TGT) and Simon Property Group (NYSE:SPG) were the names removed as part of the June update.

Related Articles

Goldman Sachs updates US Conviction List for June

Creditors file lawsuit against defaulted Chinese developer's state shareholder

India shares dive as polls show Modi's mandate slipping